Urotronic Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 20

Employees
  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $12.4M

  • Investors
  • 7

Urotronic General Information

Description

Developer of drug-coated balloon device intended to serve as a low-cost, minimally-invasive treatment option for men suffering from urinary tract conditions.. The company's device combines balloon dilation and drug delivery to uptake highly lipophilic drug, paclitaxel, limits hyperactive cell proliferation and the fibrotic scar tissue generation that results in stricture recurrence and it localizes drug delivery through micro tissue separations created by balloon expansion, ensuring that circumferential drug effectively covers the stricture, enabling doctors to treat diseases related to urology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Therapeutic Devices
Primary Office
  • 2495 Xenium Lane North
  • Plymouth, MN 55441
  • United States
+1 (763) 000-0000

Urotronic Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Urotronic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 08-Oct-2020 $12.4M 000.00 00000 Completed Generating Revenue
5. Debt - PPP 28-Apr-2020 0000 Completed Generating Revenue
4. Early Stage VC (Series B) 21-Aug-2018 000.00 0000 0000 Completed Generating Revenue
3. Early Stage VC (Series A) 29-Jun-2017 00.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A3) 08-Sep-2016 $4M $8.75M 0000 Completed Generating Revenue
1. Early Stage VC 31-Mar-2015 $4.75M $4.75M 00.000 Completed Startup
To view Urotronic’s complete valuation and funding history, request access »

Urotronic Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A4 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A3 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series A2 3,850,000 $0.000100 $1 $1 1x $1 17.37%
Series A1 3,000,000 $0.000100 $0.33 $0.33 1x $0.33 13.53%
To view Urotronic’s complete cap table history, request access »

Urotronic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drug-coated balloon device intended to serve as a low-cost, minimally-invasive treatment option for men suf
Diagnostic Equipment
Plymouth, MN
20 As of 2022
000.00
0000 0000-00-00
00000000000 000.00

000000

te velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident
0000000000 000000000
Portsmouth, NH
000 As of 0000
00000
00000000. 00

000000

it amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna ali
00000000 0000000
Redmond, WA
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Urotronic Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Laborie Medical Technologies Private Equity-Backed Portsmouth, NH 000 00000 00000000. 00
00000000000 000000 Venture Capital-Backed Redmond, WA 00 00000 00000000000 00000
000000000 0000000 Angel-Backed Brookfield, WI 00 0000 00000000000 0000
00000 Formerly VC-backed Shanghai, China 000 000.00 00000000 000.00
000000 Formerly VC-backed Mountain View, CA 00 00000 000000&0 00000
You’re viewing 5 of 7 competitors. Get the full list »

Urotronic Patents

Urotronic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3927410-A1 Drug-coated balloon catheters for body lumens Pending 22-Feb-2019 000000000
JP-2022521000-A Drug-coated balloon catheter for body cavity Pending 22-Feb-2019 000000000
US-20210361918-A1 Drug-coated balloon catheters for body lumens Pending 22-Feb-2019 000000000
EP-3442612-A4 Drug-coated balloon catheters for body lumens Active 05-May-2017 000000000
EP-3442612-B1 Drug-coated balloon catheters for body lumens Active 05-May-2017 A61P31/00
To view Urotronic’s complete patent history, request access »

Urotronic Executive Team (1)

Name Title Board Seat Contact Info
David Perry Chief Executive Officer, President and Board Member
To view Urotronic’s complete executive team members history, request access »

Urotronic Board Members (11)

Name Representing Role Since
Ching Tan Self Board Member 000 0000
David Perry Urotronic Chief Executive Officer, President and Board Member 000 0000
Douglas Kohrs Self Board Member 000 0000
Hui Hu Ph.D Self Co-Founder & Board Member 000 0000
Junfeng Wang Legend Capital Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Urotronic Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Urotronic Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Laborie Medical Technologies PE-Backed Company Minority 000 0000 000000 0
CDBI Partners Venture Capital Minority 000 0000 000000 0
Hillhouse Capital Group PE/Buyout Minority 000 0000 000000 0
HM Ventures Venture Capital Minority 000 0000 000000 0
Legend Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »